NVision Quantum Technologies

A quantum technology company developing quantum-enhanced MRI for real-time cancer diagnosis and treatment assessment, and expanding into quantum computing for drug discovery.

Active
Series B Ulm, Germany Founded 2015
Total raised
$116.8M
Last: Series B 2026-05
Stage
Series B
Founded
2015
Headcount
HQ
Ulm, Germany
Sector

About

NVision Quantum Technologies is a quantum technology company that leverages advances in quantum physics to develop and deploy next-generation metabolic MRIs for faster and more accurate cancer diagnoses and treatment assessment. The company's POLARIS platform uses quantum technology to boost MRI signals, enabling real-time measurement of metabolism on standard MRI systems. NVision is also expanding into quantum computing to accelerate the discovery and validation of new therapies by designing more effective drug candidates.

Funding history · 3 rounds · $116.8M total

2026-05
Series B $38.0M
2023-06
Series A $30.0M
2016-01
Seed $6.0M

Team · 5

Sella Brosh
Founder · CEO, Co-founder
Ilai Schwartz
Founder · Co-founder, CTO
Alex Retzker
Founder · Co-founder
Fedor Jelezko
Founder · Co-founder
Martin Plenio
Founder · Co-founder

Sectors & technology

Technologies
Target customers
Business model
B2B

Highlights

undefined Patents

Tags

quantum-technologieshealthcaremedical-imagingmricancer-diagnosisquantum-computingmedtech